The following is a partial list of research grant awards to Duke University Emergency Medicine investigators.
- Sysmex CN-6000 - D-dimer Studies for VTE Exclusion Claim
SJ Francis - Sysmex America, Inc. - 2025 – 2030 - OtoNexus Advanced Otoscope
AT Limkakeng - OtoNexus Medical Technologies, Inc. - 2025 – 2030 - MARC-45
L Siewny - Massachusetts General Hospital - 2025 – 2030 - Implementation of a Culturally Tailored Decentralization Programme for Snakebite Treatment in Indigenous Communities in the Brazilian Amazonia
JN Vissoci - Fundacao de Medicina Tropical Doutor Heitor Vieira Dourado - 2025 – 2029 - POST-ICECAP
AT Limkakeng - University of Michigan - 2024 – 2028 - Mid-Atlantic praGmatic NETwork for Involving many different, scientifically representative populations in Clinical trials in emergency care (MAGNETIC)
AT Limkakeng - National Institute of Neurological Disorders and Stroke - 2023 – 2028 - STRATEGY FOR IMPROVING STROKE TREATMENT RESPONSE (SISTER) TRIAL
AT Limkakeng - University of Cincinnati - 2024 – 2028 - Regionalization of Acute Stroke Care for Rural Populations: A Systems Modeling Approach
MD Patel - National Institute on Minority Health and Health Disparities - 2026 – 2028 - ED NSTEMI
AT Limkakeng - Roche Diagnostics Corporation - 2025 – 2027 - HeadSMART II
SP Shaheen - BRAINBox Solutions, Inc - 2022 – 2027 - Improving access to cancer care for children in Tanzania: Designing a health-systems intervention
ER Smith - Fogarty International Center - 2022 – 2027 - Improving quality of care for older adult trauma patients in Tanzania: an adaptation of guidelines for low resource settings.
CA Staton - Good Samaritan Foundation (KCMC) - 2025 – 2027 - PRICE- Alcohol: Planning the Regional Implementation of a Culturally Adapted Brief Intervention for Alcohol for Tanzanian Emergency Departments
CA Staton - National Institute on Alcohol Abuse & Alcoholism - 2024 – 2027 - Simulation-based ultrasound workshop feasibility and impact assessment RG Theophanous - Society for Academic Emergency Medicine - 2026 – 2027
- A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19
J Eppensteiner - Regeneron Pharmaceuticals, Inc. - 2020 – 2026 - Understanding the Barriers and Facilitators to the Delivery of Regional Evidence Based Pediatric Burn Care
ER Hanlin - Emergency Medicine Foundation - 2025 – 2026 - Developing an intervention to improve quality of myocardial infarction care in northern Tanzania
J Hertz - National Heart, Lung, and Blood Institute - 2021 – 2026 - Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT)
AT Limkakeng - University of Michigan - 2025 – 2026 - Systematic and Standardized Recording and Analysis of Patient Encounters and Medical Resource Use
JN Vissoci - Federation Internationale de Football Association - 2026 – 2026 - Regional Trauma Systems of Care to Address Rural Disparities in Injury Mortality
MD Patel - University of North Carolina - Chapel Hill - 2026 – 2026 - Capacity building for injury and trauma care implementation and data science research training
CA Staton - Kilimanjaro Christian Medical Centre - 2021 – 2026 - PRACT: A Pragmatic Randomized Adaptive Clinical Trial to Investigate Controlling Alcohol related harms in a Low-Income Setting; Emergency Department Brief Interventions in Tanzania
CA Staton - National Institute on Alcohol Abuse & Alcoholism - 2020 – 2026 - Emergency physician ultrasound-guided nerve block training simulation assessment
RG Theophanous - Society for Academic Emergency Medicine - 2025 – 2026 - Ketone Ester Supplement for CNSOT Mitigation
BJ Derrick - Naval Sea Systems Command - 2022 – 2025 - Randomized, double-blind, placebo healthy volunteer exercising at altitude
BJ Derrick - Diffusion Pharmaceuticals - 2021 – 2025 - Secondary Analysis of BRAVO Pro00108196
CJ Gerardo - Ophirex, Inc - 2024 – 2025 - Snakebite OPX-PR-01
CJ Gerardo - Ophirex, Inc - 2021 – 2025 - Snakebite Study #2- Pro00112601
CJ Gerardo - Ophirex, Inc - 2023 – 2025 - Duke NUS
AP Joiner - National University of Singapore - 2021 – 2025 - PERFORM-TSIX Study - Pro00110924
AT Limkakeng - Roche Diagnostics Corporation - 2022 – 2025 - Specimen Collection for the Evaluation of Alere NT-proBNP for Alinity i System in Emergency Department Setting for Heart Failure (LANER-HF)
AT Limkakeng - Abbott Laboratories - 2022 – 2025 - Understanding patient perspective in ED triage: Opportunities to reduce bias in intake psychiatric patients
Nickenig Vissoci, Joao Ricardo - Society for Academic Emergency Medicine - 2023 – 2025 - Primary Ear and Hearing Care, Children's Minnesota - Duke Collaboration
CA Staton - Children's Minnesota - 2024 – 2025 - Impact of climate change and land use on snakebite envenoming in the Brazilian Amazon
CJ Gerardo - Fogarty International Center - 2022 – 2024 - Using community health centers to mitigate the impact of snakebite envenoming in low resource areas
CJ Gerardo - Fogarty International Center - 2021 – 2024 - NBME OSCE for Clinical Reasoning Creative Community
DC Gordon - National Board of Medical Examiners - 2022 – 2024 - A prospective, non randomized, sequentially enrolled phase II to evaluate SENSE device to detect tramatic brain injury
AT Limkakeng - Sense Diagnostics, Inc - 2022 – 2024 - Administrative Supplement to Support Strategies to Increase Participant Diversity, Inclusion and Engagement in EPPIC NET
AT Limkakeng - National Institute of Neurological Disorders and Stroke – 2021 – 2024 - CRISPR-based, rapid bedside bacteremia detection for ED sepsis management
AT Limkakeng - Society for Academic Emergency Medicine - 2023 – 2024 - Jiaxing WISETEST - Clinical Evaluation - Pro00111528
AT Limkakeng - Jiaxing WiseTest Bio-Tech Co., Ltd. - 2022 – 2024 - Jiaxing WISETEST - Professional Use - Pro00111529
AT Limkakeng - Jiaxing WiseTest Bio-Tech Co., Ltd. - 2022 – 2024 - POC Troponin Study - Pro00110283
AT Limkakeng - Quidel - 2022 – 2024 - Sen-Jam Pharmaceuticals - COVID Ketoifen/Indomethacin study
AT Limkakeng - Sen-Jam Pharmaceutical - 2021 – 2024 - Sense Diagnostics
AT Limkakeng - Sense Diagnostics, Inc - 2021 – 2024